RA0272

antibody from Oursmab

Targeting: GDF15 MIC-1, MIC1, NAG-1, PDF, PLAB, PTGFB

Western blot (Supportive data in Antibodypedia)

ELISA (Supportive data in Antibodypedia)

Immunocytochemistry (Recommended by provider)

Flow cytometry (Recommended by provider)

Functional assay (Recommended by provider)

Antibody Data

Product number

RA0272

Provider

Oursmab

Product name

Visugromab (Biosimilar Reference Antibody) (GDF15)

Antibody type

Monoclonal

Description

Visugromab (CTL-002) is an investigational human monoclonal antibody that specifically targets and neutralizes Growth Differentiation Factor 15 (GDF-15). It is being developed primarily for use in oncology, aimed at reversing GDF-15-mediated T-cell suppression within the tumor microenvironment, thereby potentially restoring anti-tumor immune responses, especially in combination with immune checkpoint inhibitors.

Reactivity

Human

Isotype

IgG

Vial size

100 ¦Ìg,1 mg,5 mg,10 mg,25 mg,50 mg,100 mg

Concentration

Bottled at the concentration indicated on the vial.

Storage

Store at -20¡ãC or -80¡ãC. Avoid repeated freeze.

Western blot

Supportive validation

Submitted by

Oursmab (provider)

Main image

Experimental details

Visugromab (Biosimilar Reference Antibody) (GDF15)-RA0272-Oursmab determined by SDS-PAGE. The purity of the protein is greater than 98%.

ELISA

Supportive validation

Submitted by

Oursmab (provider)

Main image

Experimental details

ELISA plate pre-coated Antigen protein, can bind Visugromab biosimilar in a linear range of 3.91-125 ng/mL.